Additionally, two cases had ongoing seizures after surgery or ASMs but were treated effectively by receiving KD, suggesting that KD may be a potential option for patients of NPRL3-related epilepsy unresponsive to surgery or ASMs. The gene discussed is NPRL3; the disease is epilepsy.